Terms: = Breast cancer AND RAD51B, ENSG00000182185, 5890, RAD51L1, O15315, hREC2, R51H2, REC2, MGC34245 AND Prognosis
5 results:
1. Systematic proximal mapping of the classical RAD51 paralogs unravel functionally and clinically relevant interactors for genome stability.
Simo Cheyou E; Boni J; Boulais J; Pinedo-Carpio E; Malina A; Sherill-Rofe D; Luo VM; Goncalves C; Bagci H; Maters A; Cuella-Martin R; Tabach Y; Del Rincon S; Côté JF; Rivera B; Orthwein A
PLoS Genet; 2022 Nov; 18(11):e1010495. PubMed ID: 36374936
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive Analysis of Prognostic and Immune Infiltrates for RAD51 in Human breast cancer.
Li F; Zhang Y; Shi Y; Liu S
Crit Rev Eukaryot Gene Expr; 2021; 31(4):71-79. PubMed ID: 34587437
[TBL] [Abstract] [Full Text] [Related]
3. breast-conserving therapy shows better prognosis in mucinous breast carcinoma compared with mastectomy: A SEER population-based study.
Yu P; Liu P; Zou Y; Xie X; Tang H; Li N; Xie X; Ye F
Cancer Med; 2020 Aug; 9(15):5381-5391. PubMed ID: 32515157
[TBL] [Abstract] [Full Text] [Related]
4. The relationship between eight GWAS-identified single-nucleotide polymorphisms and primary breast cancer outcomes.
Bayraktar S; Thompson PA; Yoo SY; Do KA; Sahin AA; Arun BK; Bondy ML; Brewster AM
Oncologist; 2013; 18(5):493-500. PubMed ID: 23635555
[TBL] [Abstract] [Full Text] [Related]
5. Novel genetic markers of breast cancer survival identified by a genome-wide association study.
Shu XO; Long J; Lu W; Li C; Chen WY; Delahanty R; Cheng J; Cai H; Zheng Y; Shi J; Gu K; Wang WJ; Kraft P; Gao YT; Cai Q; Zheng W
Cancer Res; 2012 Mar; 72(5):1182-9. PubMed ID: 22232737
[TBL] [Abstract] [Full Text] [Related]
